• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.维生素 D 作为卡氏肺孢子虫肺炎补充治疗的作用机制。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01226-17. Print 2017 Oct.
2
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.维生素D作为肺孢子菌肺炎的补充治疗方法。
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1289-97. doi: 10.1128/AAC.02607-15.
3
All-trans retinoic acid in combination with primaquine clears pneumocystis infection.全反式维甲酸联合伯氨喹可清除卡氏肺孢子虫感染。
PLoS One. 2013;8(1):e53479. doi: 10.1371/journal.pone.0053479. Epub 2013 Jan 4.
4
Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients.克林霉素-伯氨喹治疗肾移植术后患者肺孢子菌肺炎。
Infection. 2014 Dec;42(6):981-9. doi: 10.1007/s15010-014-0660-y. Epub 2014 Aug 29.
5
Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.卡泊芬净联合复方磺胺甲噁唑治疗肺部卡氏肺孢子虫肺炎的实验研究。
PLoS One. 2013 Aug 5;8(8):e70619. doi: 10.1371/journal.pone.0070619. Print 2013.
6
Prognostic factors and clinical efficacy of second-line treatments of Pneumocystis jirovecii pneumonia for non-HIV patients after first-line treatment failure.一线治疗失败后非 HIV 患者肺孢子菌肺炎二线治疗的预后因素和临床疗效。
BMC Infect Dis. 2022 Jun 14;22(1):546. doi: 10.1186/s12879-022-07523-y.
7
Clindamycin-primaquine versus pentamidine for the second-line treatment of pneumocystis pneumonia.克林霉素-伯氨喹与喷他脒二线治疗卡氏肺孢子虫肺炎。
J Infect Chemother. 2009 Oct;15(5):343-6. doi: 10.1007/s10156-009-0710-z. Epub 2009 Oct 24.
8
The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of pneumonia in patients with rheumatic diseases.降低剂量的磺胺甲噁唑-甲氧苄啶预防风湿性疾病患者肺炎的疗效和安全性。
Mod Rheumatol. 2021 May;31(3):629-635. doi: 10.1080/14397595.2020.1812834. Epub 2020 Sep 9.
9
Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.艾滋病相关耶氏肺孢子菌肺炎的二线挽救治疗:病例系列及系统评价
J Acquir Immune Defic Syndr. 2008 May 1;48(1):63-7. doi: 10.1097/QAI.0b013e31816de84d.
10
Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.艾滋病患者轻度和中度严重卡氏肺孢子虫肺炎的克林霉素联合伯氨喹与甲氧苄啶-磺胺甲恶唑治疗对比:一项多中心、双盲、随机试验(CTN 004)。CTN-PCP研究组
Clin Infect Dis. 1998 Sep;27(3):524-30. doi: 10.1086/514696.

引用本文的文献

1
Vitamin D immune modulation of the anti-inflammatory effects of HDL-associated proteins.维生素D对高密度脂蛋白相关蛋白抗炎作用的免疫调节
Lipids Health Dis. 2025 Jul 31;24(1):257. doi: 10.1186/s12944-025-02639-x.
2
Role of vitamin D in COVID-19 and other viral infections.维生素D在新冠病毒感染及其他病毒感染中的作用。
World J Virol. 2024 Sep 25;13(3):95349. doi: 10.5501/wjv.v13.i3.95349.
3
Correlation of vitamin D levels with serum parameters in Covid-19 patients.新型冠状病毒肺炎患者维生素 D 水平与血清学参数的相关性。
Clin Nutr ESPEN. 2023 Jun;55:325-331. doi: 10.1016/j.clnesp.2023.04.012. Epub 2023 Apr 19.
4
Relationship between Vitamin D and Immunity in Older People with COVID-19.维生素 D 与 COVID-19 老年患者免疫功能的关系。
Int J Environ Res Public Health. 2023 Apr 7;20(8):5432. doi: 10.3390/ijerph20085432.
5
Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诊断与治疗方案的评估
J Family Med Prim Care. 2022 Aug;11(8):4219-4227. doi: 10.4103/jfmpc.jfmpc_1735_21. Epub 2022 Aug 30.
6
Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.维生素 D - 预防 COVID-19 感染的主要免疫调节剂。
Int J Rheum Dis. 2023 Jan;26(1):13-30. doi: 10.1111/1756-185X.14477. Epub 2022 Oct 29.
7
Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic.维生素D水平及补充剂对新冠疫情期间系统性红斑狼疮患者的影响
Arch Rheumatol. 2022 Mar 3;37(2):288-299. doi: 10.46497/ArchRheumatol.2022.8996. eCollection 2022 Jun.
8
Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress.重症 COVID-19 的特征是血浆胺类物质紊乱,与免疫反应标志物相关,并与炎症和氧化应激有关。
Metabolites. 2022 Jul 2;12(7):618. doi: 10.3390/metabo12070618.
9
Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients' Outcomes-A Single-Center Experience and a Brief Review of the Literature.COVID-19 患者血清维生素 D 水平低与炎症标志物和患者预后无关:一项单中心经验及文献复习。
Nutrients. 2022 May 10;14(10):1998. doi: 10.3390/nu14101998.
10
Vitamin D Regulation of Immune Function.维生素 D 对免疫功能的调节。
Curr Osteoporos Rep. 2022 Jun;20(3):186-193. doi: 10.1007/s11914-022-00732-z. Epub 2022 May 4.

本文引用的文献

1
The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.维生素D类似物帕立骨化醇通过下调大鼠Toll样受体4信号传导减轻肝脏缺血/再灌注损伤。
Arch Med Sci. 2017 Mar 1;13(2):459-469. doi: 10.5114/aoms.2016.60650. Epub 2016 Jun 17.
2
Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.1α,25-二羟基维生素D3对效应性CD4+ T细胞诱导的人肾近端小管上皮细胞损伤的保护作用
PLoS One. 2017 Feb 28;12(2):e0172536. doi: 10.1371/journal.pone.0172536. eCollection 2017.
3
Vitamin D3 pretreatment protects against lipopolysaccharide-induced early embryo loss through its anti-inflammatory effects.维生素D3预处理通过其抗炎作用预防脂多糖诱导的早期胚胎丢失。
Am J Reprod Immunol. 2017 Mar;77(3). doi: 10.1111/aji.12620. Epub 2017 Jan 3.
4
1,25-dihydroxyvitamin D down-modulates the production of proinflammatory cytokines and nitric oxide and enhances the phosphorylation of monocyte-expressed STAT6 at the recent-onset type 1 diabetes.1,25-二羟基维生素D可下调近期发病的1型糖尿病中促炎细胞因子和一氧化氮的产生,并增强单核细胞表达的信号转导和转录激活因子6(STAT6)的磷酸化。
Immunol Lett. 2016 Nov;179:122-130. doi: 10.1016/j.imlet.2016.10.002. Epub 2016 Oct 4.
5
Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia.血浆白细胞介素-6/白细胞介素-10比值以及白细胞介素-8、乳酸脱氢酶和α-羟丁酸脱氢酶水平可预测艾滋病合并肺孢子菌肺炎患者的病情严重程度及死亡风险。
J Immunol Res. 2016;2016:1583951. doi: 10.1155/2016/1583951. Epub 2016 Aug 7.
6
Effect of 1,25-dihydroxyvitamin D3 on the expression of mannose receptor, DC-SIGN and autophagy genes in pulmonary tuberculosis.1,25-二羟基维生素D3对肺结核中甘露糖受体、DC-SIGN及自噬基因表达的影响
Tuberculosis (Edinb). 2016 Jul;99:1-10. doi: 10.1016/j.tube.2016.03.010. Epub 2016 Apr 2.
7
Advances in Autophagy Regulatory Mechanisms.自噬调控机制的进展
Cells. 2016 May 13;5(2):24. doi: 10.3390/cells5020024.
8
Association between levels of vitamin D and inflammatory markers in healthy women.健康女性体内维生素D水平与炎症标志物之间的关联。
J Inflamm Res. 2016 Apr 27;9:51-7. doi: 10.2147/JIR.S103298. eCollection 2016.
9
Vitamin D3 alters Toll-like receptor 4 signaling in monocytes of pregnant women at risk for preeclampsia.维生素D3改变子痫前期高危孕妇单核细胞中Toll样受体4信号通路。
Int J Clin Exp Med. 2015 Oct 15;8(10):18041-9. eCollection 2015.
10
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.维生素D作为肺孢子菌肺炎的补充治疗方法。
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1289-97. doi: 10.1128/AAC.02607-15.

维生素 D 作为卡氏肺孢子虫肺炎补充治疗的作用机制。

Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

机构信息

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chiayi, Taiwan.

出版信息

Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01226-17. Print 2017 Oct.

DOI:10.1128/AAC.01226-17
PMID:28760906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5610499/
Abstract

The combination of trimethoprim and sulfamethoxazole (TMP-SMX) is the most effective regimen for therapy of pneumonia (PCP). As many patients with PCP are allergic or do not respond to it, efforts have been devoted to develop alternative therapies for PCP. We have found that the combination of vitamin D (VitD3) (300 IU/kg/day) and primaquine (PMQ) (5 mg/kg/day) was as effective as TMP-SMX for therapy of PCP. In this study, we investigated the mechanisms by which vitamin D enhances the efficacy of PMQ. C57BL/6 mice were immunosuppressed by CD4 cell depletion, infected with for 8 weeks, and then treated for 9 days with the combination of VitD3 and PMQ (VitD3-PMQ) or with TMP-SMX or PMQ to serve as controls. The results showed that vitamin D supplementation increased the number of CD11c cells, suppressed the production of proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], gamma interferon [IFN-γ], and interleukin-6 [IL-6]) and inducible nitric oxide synthase (iNOS), and enhanced the expression of genes related to antioxidation (glutathione reductase and glutamate-cysteine ligase modifier subunit), antimicrobial peptides (cathelicidin), and autophagy (ATG5 and beclin-1). These results suggest that the main action of vitamin D is enhancing the ability of the host to defend against infection.

摘要

复方磺胺甲噁唑(TMP-SMX)是治疗肺炎(PCP)最有效的方案。由于许多患有 PCP 的患者对此过敏或无反应,因此人们一直致力于开发治疗 PCP 的替代疗法。我们发现,维生素 D(VitD3)(300 IU/kg/天)和伯氨喹(PMQ)(5 mg/kg/天)联合治疗 PCP 的效果与 TMP-SMX 相当。在这项研究中,我们研究了维生素 D 增强 PMQ 疗效的机制。用 CD4 细胞耗竭使 C57BL/6 小鼠免疫抑制,用感染 8 周,然后用 VitD3 和 PMQ(VitD3-PMQ)联合或用 TMP-SMX 或 PMQ 治疗 9 天作为对照。结果表明,维生素 D 补充增加了 CD11c 细胞的数量,抑制了促炎细胞因子(肿瘤坏死因子-α[TNF-α]、γ干扰素[IFN-γ]和白细胞介素-6[IL-6])和诱导型一氧化氮合酶(iNOS)的产生,并增强了与抗氧化(谷胱甘肽还原酶和谷氨酸-半胱氨酸连接酶修饰亚基)、抗菌肽(cathelicidin)和自噬(ATG5 和 beclin-1)相关的基因表达。这些结果表明,维生素 D 的主要作用是增强宿主抵御感染的能力。